These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9492055)
1. Demonstration of a relaxin receptor and relaxin-stimulated tyrosine phosphorylation in human lower uterine segment fibroblasts. Palejwala S; Stein D; Wojtczuk A; Weiss G; Goldsmith LT Endocrinology; 1998 Mar; 139(3):1208-12. PubMed ID: 9492055 [TBL] [Abstract][Full Text] [Related]
2. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Palejwala S; Stein DE; Weiss G; Monia BP; Tortoriello D; Goldsmith LT Endocrinology; 2001 Aug; 142(8):3405-13. PubMed ID: 11459784 [TBL] [Abstract][Full Text] [Related]
3. Effect of relaxin on bound cAMP in rat uterus. Sanborn BM; Sherwood OD Endocr Res Commun; 1981; 8(3):179-92. PubMed ID: 6174316 [TBL] [Abstract][Full Text] [Related]
4. Relaxin signalling in primary cultures of human myometrial cells. Heng K; Ivell R; Wagaarachchi P; Anand-Ivell R Mol Hum Reprod; 2008 Oct; 14(10):603-11. PubMed ID: 18805799 [TBL] [Abstract][Full Text] [Related]
5. Binding and cross-linking of 32P-labeled human relaxin to human uterine cells and primary rat atrial cardiomyocytes. Osheroff PL; King KL Endocrinology; 1995 Oct; 136(10):4377-81. PubMed ID: 7664657 [TBL] [Abstract][Full Text] [Related]
6. Preparation of biologically active 32P-labeled human relaxin. Displaceable binding to rat uterus, cervix, and brain. Osheroff PL; Ling VT; Vandlen RL; Cronin MJ; Lofgren JA J Biol Chem; 1990 Jun; 265(16):9396-401. PubMed ID: 2160976 [TBL] [Abstract][Full Text] [Related]
7. Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment. Tan YY; Wade JD; Tregear GW; Summers RJ Br J Pharmacol; 1999 May; 127(1):91-8. PubMed ID: 10369460 [TBL] [Abstract][Full Text] [Related]
8. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3). van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943 [TBL] [Abstract][Full Text] [Related]
9. Relaxin receptors in mice: demonstration of ligand binding in symphyseal tissues and uterine membrane fragments. Yang S; Rembiesa B; Büllesbach EE; Schwabe C Endocrinology; 1992 Jan; 130(1):179-85. PubMed ID: 1309327 [TBL] [Abstract][Full Text] [Related]
10. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity. Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of relaxin and progesterone on cyclic adenosine 3',5'-monophosphate levels in the rat uterus. Grazi RV; Goldsmith LT; Schmidt CL; Von Hagen S; Weiss G Am J Obstet Gynecol; 1988 Dec; 159(6):1402-6. PubMed ID: 2462790 [TBL] [Abstract][Full Text] [Related]
12. Comparison of relaxin receptors in rat isolated atria and uterus by use of synthetic and native relaxin analogues. Tan YY; Wade JD; Tregear GW; Summers RJ Br J Pharmacol; 1998 Feb; 123(4):762-70. PubMed ID: 9517397 [TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors. Aronica SM; Katzenellenbogen BS Endocrinology; 1991 Apr; 128(4):2045-52. PubMed ID: 1706263 [TBL] [Abstract][Full Text] [Related]
14. Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture. Kramer SM; Gibson UE; Fendly BM; Mohler MA; Drolet DW; Johnston PD In Vitro Cell Dev Biol; 1990 Jun; 26(6):647-56. PubMed ID: 2162818 [TBL] [Abstract][Full Text] [Related]
15. RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway. Dschietzig T; Bartsch C; Baumann G; Stangl K Regul Pept; 2009 Apr; 154(1-3):77-84. PubMed ID: 19101597 [TBL] [Abstract][Full Text] [Related]
17. Modulation of cyclic AMP in isolated rat uterine tissue slices by porcine relaxin. Judson DG; Pay S; Bhoola KD J Endocrinol; 1980 Oct; 87(1):153-9. PubMed ID: 6253589 [TBL] [Abstract][Full Text] [Related]
18. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors. Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682 [TBL] [Abstract][Full Text] [Related]
19. Relaxin receptor LGR7 (RXFP1) is regulated by estrogen. Maseelall P; Gardner J; Wojtczuk A; Weiss G; Goldsmith LT Ann N Y Acad Sci; 2009 Apr; 1160():91-2. PubMed ID: 19416165 [TBL] [Abstract][Full Text] [Related]
20. Tissue-specific effects of relaxin on the reproductive tract of neonatal gilts. Yan W; Wiley AA; Bartol FF; Bagnell CA Ann N Y Acad Sci; 2005 May; 1041():132-5. PubMed ID: 15956697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]